Comparing the current results to its competitors, Clearpoint Neuro Inc reported Revenue increase in the 1 quarter 2026 by 42.93 % year on year. The sales growth was above Clearpoint Neuro Inc 's competitors' average revenue growth of 8.92 %, achieved in the same quarter.
Clearpoint Neuro Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 28.5 %
Strong sales growth of 42.93 % in Overall company contributed to Clearpoint Neuro Inc increase in total revenue by 42.93 % Clearpoint Neuro Inc improved its market share in this segment, to approximately 0.04 %.
June 20, 2024
ClearPoint Neuro, a global leader in intraoperative neurosurgical planning and navigation solutions, is pleased to announce a significant milestone achieved by its valued partner, Aspen Neuroscience. The renowned ClearPoint Navigation System will be utilized for all enrolled patients participating in Aspen s groundbreaking ASPIRO clinical trial. This trial aims to evaluate the efficacy of Parkinson s cell therapy in patients with advanced Parkinson s disease.Aspen Neuroscience, a biotechnology company focused on developing novel cell-based therapies for neurological conditions, has recognized the advantages offered by ClearPoint Navigation System s precision and accuracy. The system s advanced technology aid...
March 11, 2024
Journal of Neurosurgery Publication Highlights ClearPoint Prism Neuro Laser Therapy System s Unparalleled Efficiency and PrecisionIn an exciting development, ClearPoint Neuro has recently released a peer-reviewed publication in the esteemed Journal of Neurosurgery showcasing the remarkable advantages of their innovative ClearPoint Prism Neuro Laser Therapy System. The study, centered on the correlation of software lesion size to histopathology, sheds light on the system s exceptional accuracy and effectiveness, solidifying its position as the only FDA-cleared laser therapy system with such correlation.The ClearPoint Prism Neuro Laser Therapy System represents a groundbreaking leap forward in the field of neu...
February 21, 2024
ClearPoint Neuro, a leading medical technology company specializing in advanced neuroscience solutions, has recently achieved a series of significant milestones that are set to transform the field of neurosurgery. The company has announced the FDA clearance and successful first-in-human cases using the highly anticipated 2.2 Software version, uniquely integrated with the revolutionary Maestro Brain Model. This groundbreaking development has been met with great enthusiasm within the medical community.The integration of ClearPoint Neuro s 2.2 Software with the Maestro Brain Model marks a major advancement in precision-guided neurosurgery. By combining advanced imaging techniques with real-time feedback, surgeo...
January 22, 2024
ClearPoint Neuro, a leading medical technology company based in Carlsbad, California, has recently achieved a significant milestone by obtaining its first European Union Medical Device Regulation (EU MDR) certification. This achievement not only marks a major success for the company but also paves the way for ClearPoint Neuro to introduce its groundbreaking product lineup to the European market.The EU MDR certification is a rigorous regulatory requirement that ensures the safety, quality, and performance of medical devices being marketed in the European Union. ClearPoint Neuro s successful attainment of this certification demonstrates its unwavering commitment to upholding the highest standards and meeting t...
Neuropace Inc's business model revolves around the development and commercialization of medical devices for the treatment of neurological disorders, primarily focusing on epilepsy.
Merit Medical Systems Inc operates as a medical device company that develops, manufactures, and distributes disposable medical devices. Their business model focuses on delivering high-quality and innovative products to healthcare professionals and hospitals worldwide. They generate revenue through the sales and distribution of their medical devices, aiming to improve patient outcomes and provide value to healthcare providers.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Medinotec Inc is a medical technology company that operates on a business model focused on developing and providing innovative healthcare solutions, such as medical devices and software, to improve patient care and outcomes. Their products and services cater to healthcare professionals and institutions, offering advanced technology solutions in the medical field.
Sources:
Clearpoint Neuro Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Clearpoint Neuro Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
